Global Statistics

All countries
163,714,287
Confirmed
Updated on May 16, 2021 9:47 pm
All countries
143,319,369
Recovered
Updated on May 16, 2021 9:47 pm
All countries
3,393,280
Deaths
Updated on May 16, 2021 9:47 pm
Sunday, May 16, 2021

Global Statistics

All countries
163,714,287
Confirmed
Updated on May 16, 2021 9:47 pm
All countries
143,319,369
Recovered
Updated on May 16, 2021 9:47 pm
All countries
3,393,280
Deaths
Updated on May 16, 2021 9:47 pm
Molderizer and Safe Shield

Hyderabad Startup Develops Stem-Cell Based Treatment For Covid-19

Coronavirus latest: India export ban leaves global jab supply far behind schedule, says Unicef

Before coronavirus arrived in the UK, only 3.8 per cent of the country’s 812,000 call centre workers were based at home, according to...

Covid-19 Live News Tracker: Global Updates on Vaccines and Cases

Here’s what you need to know:Dr. Rochelle P. Walensky during a Senate Health, Education, Labor and Pensions Committee hearing last week.Credit...Pool photo by...

Coronavirus US: death toll tops 160,000 as relief package impasse continues live updates

More than 6000 British Airways staff have accepted voluntary redundancy as the airline moves to tell thousands more cabin crew and ground staff whether...

Working from home improving mental health of dads much more than moms: study

by: Kevin Torres/KDVR, Nexstar Media Wire Posted: May 16, 2021 / 12:42 PM EDT / Updated: May 16, 2021 / 12:42 PM EDT


A biotech startup, incubated at the ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH), may have found a treatment for Covid-19 that is based on a human umbilical cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs).

Covid-19 patient
AFP/Representational image

Transcell Oncologics, which uses cell-based products and solutions to treat cancer and other chronic diseases, has now developed a proprietary cell-based platform technology ‘HEMATO UC-MSCs’ with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities for Covid-19 treatment.

In extreme Covid-19 cases, patients have high levels of immune system proteins called cytokines in their blood. With the excessive production of pro-inflammatory cytokines, so-called “cytokine storm”, the body starts to attack its own cells and tissues rather than just fighting off the virus resulting in multi-organ failure and death.

Researchers in thin coveralls and rubber gloves handle bats while gathering samples in a clip filmed by a Chinese television crew
Image For Representation/AP

Also Read: IIT Madras Studying Coronavirus Spike Protein For Permanent Covid-19 Treatment

The treatment significantly decreases the cytokines, improving patient survival and time to recovery. The research recommends HEMATO UC-MSCs to be administered as “two intravenous infusions, at a dose of 100 million cells per infusion, given 72 hours apart to the Covid patients”.

“The advantage of the therapy is this new way of curing covid patients in real time to SAVE them and NOT to treat the symptoms alone,” founder-CEO Subhadra Dravida said in a statement.

“Also, if HEMATO UC-MSCs are administered as the first line of treatment followed by concomitant steps to alleviate the associated symptoms in a traditional way, Covid deaths can be dodged.”

covid-19 vaccine in india
Reuters

Dravida said that this stem-cell based treatment is already being used by several hospitals in Hyderabad and Telangana to save Covid-19 patients, while hospitals in other cities are also gearing up to start the treatment.

It can be delivered across the country within 48 hours and has been specially treated for storage under 2-8 degree Celsius refrigerated conditions for ease of use by the practitioners within 72 hours.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Coronavirus latest: India export ban leaves global jab supply far behind schedule, says Unicef

Before coronavirus arrived in the UK, only 3.8 per cent of the country’s 812,000 call centre workers were based at home, according to...

Covid-19 Live News Tracker: Global Updates on Vaccines and Cases

Here’s what you need to know:Dr. Rochelle P. Walensky during a Senate Health, Education, Labor and Pensions Committee hearing last week.Credit...Pool photo by...

Coronavirus US: death toll tops 160,000 as relief package impasse continues live updates

More than 6000 British Airways staff have accepted voluntary redundancy as the airline moves to tell thousands more cabin crew and ground staff whether...

Related Articles

Coronavirus latest: India export ban leaves global jab supply far behind schedule, says Unicef

Before coronavirus arrived in the UK, only 3.8 per cent of the country’s 812,000 call centre workers were based at home, according to...

Covid-19 Live News Tracker: Global Updates on Vaccines and Cases

Here’s what you need to know:Dr. Rochelle P. Walensky during a Senate Health, Education, Labor and Pensions Committee hearing last week.Credit...Pool photo by...

Coronavirus US: death toll tops 160,000 as relief package impasse continues live updates

More than 6000 British Airways staff have accepted voluntary redundancy as the airline moves to tell thousands more cabin crew and ground staff whether...